Genenta Science S.p.A.
GNTA
$2.30
$0.010.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -17.94% | -24.57% | 2.90% | 4.96% | -14.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.05% | -27.42% | 5.30% | 7.42% | -34.30% |
| Operating Income | 21.05% | 27.42% | -5.30% | -7.42% | 34.30% |
| Income Before Tax | 0.09% | 8.15% | 1.23% | -0.76% | 40.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.09% | 8.15% | 1.23% | -0.76% | 40.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.09% | 8.15% | 1.23% | -0.76% | 40.92% |
| EBIT | 21.05% | 27.42% | -5.30% | -7.42% | 34.30% |
| EBITDA | 20.99% | 27.36% | -5.31% | -7.42% | 34.42% |
| EPS Basic | 2.77% | 10.66% | 1.66% | -0.34% | 41.06% |
| Normalized Basic EPS | 2.82% | 10.53% | 1.55% | -0.33% | 41.05% |
| EPS Diluted | 2.77% | 10.66% | 1.66% | -0.34% | 41.06% |
| Normalized Diluted EPS | 2.82% | 10.53% | 1.55% | -0.33% | 41.05% |
| Average Basic Shares Outstanding | 2.80% | 2.80% | 0.40% | 0.40% | 0.22% |
| Average Diluted Shares Outstanding | 2.80% | 2.80% | 0.40% | 0.40% | 0.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |